{
    "Trade/Device Name(s)": [
        "Safecare Urinary Tract Infection Test"
    ],
    "Submitter Information": "Safecare Biotech (Hangzhou) Co., Ltd.",
    "510(k) Number": "K242767",
    "Predicate Device Reference 510(k) Number(s)": [
        "K231045"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JMT",
        "LJX"
    ],
    "Summary Letter Date": "December 9, 2024",
    "Summary Letter Received Date": "December 9, 2024",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1510"
    ],
    "Regulation Name(s)": [
        "Nitrite (Nonquantitative) Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Leukocytes",
        "Nitrite"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Colorimetric pad"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Semi-quantitative detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Strip test"
    ],
    "Document Summary": "FDA 510(k) summary for Safecare Urinary Tract Infection Test, a colorimetric urine strip for home screening of leukocytes and nitrite.",
    "Indications for Use Summary": "For the qualitative detection of leukocytes (LEU, white blood cells) in urine for over-the-counter home use.",
    "fda_folder": "Clinical Chemistry"
}